1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA UNC79 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA TCERG1L CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA ARID1B CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA SEPT5 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA C20orf24 CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA DHPS CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA PFDN4 CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA LRRC34 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA TUBA1A CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA GP1BB CTRPv2 pan-cancer AAC 0.17 1e-06
Download CSV